Filing Details
- Accession Number:
- 0001209191-22-009417
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-14 17:28:17
- Reporting Period:
- 2022-01-03
- Accepted Time:
- 2022-02-14 17:28:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1720580 | Adicet Bio Inc. | ACET | Pharmaceutical Preparations (2834) | 813305277 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1823901 | Aya Jakobovits | C/O Adicet Bio, Inc. 200 Clarendon Street, Floor 6 Boston MA 02116 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-01-03 | 6,000 | $18.02 | 366,343 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2022-01-03 | 6,000 | $18.02 | 366,345 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2022-01-05 | 2,000 | $16.93 | 364,343 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2022-01-05 | 2,000 | $16.90 | 364,345 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2022-02-09 | 4,000 | $14.03 | 360,343 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2022-02-09 | 4,000 | $14.03 | 360,345 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 138,076 | Indirect | See Footnote |
Footnotes
- These sales were effected pursuant to Rule 10b5-1 trading plans previously adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' daughter is the beneficiary.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' son is the beneficiary.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.41 to $17.38. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.41 to $17.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.00 to $14.26. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- Shares held in a revocable trust of which Dr. Jakobovits and her spouse are co-trustees.